New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Editor's Top Picks
Tailored drug combinations show promise against treatment-resistant melanoma in preclinical study
Researchers at MD Anderson Cancer Center have developed a strategy to match drug combinations to tumor biomarkers in treatment-resistant melanoma,…
Submit Your Paper →
More form New Studies
Healthy Diet and Exercise Cut Disease Risk Even Without Weight Loss, Major US Study Finds
New analysis of three US cohorts published in The Lancet Regional Health—Americas shows that physical…
Community Health Workers Boost COVID-19 Testing Among Formerly Incarcerated People
A randomized controlled trial published in The Lancet Public Health demonstrates that community health workers…
Aging Activates Belly Fat Stem Cells: New Clues to Middle-Age Weight Gain
Aging activates specialized stem cells in abdominal tissue that accelerate belly fat production, according to…
FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells
Researchers have identified that rare liver cancers evade immunotherapy by trapping immune T cells in…
Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention Strategy
A randomized controlled trial published in the New England Journal of Medicine (June 2026) compares…